Preclinical study on an adsorbed acellular diphtheria- tetanus-pertussis (reduced-dose) combined vaccine: evaluation of reproductive safety and immunogenicity.
Saved in:
| Title: | Preclinical study on an adsorbed acellular diphtheria- tetanus-pertussis (reduced-dose) combined vaccine: evaluation of reproductive safety and immunogenicity. |
|---|---|
| Authors: | Chu H; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Kong W; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Gu Q; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Ma Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Cai L; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Li J; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Wang X; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Ji Q; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Wen J; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Gao N; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Ji G; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Hu W; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Zhao T; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Ping L; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Fu Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China., Li Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Gong T; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Jin Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Yang Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Fu Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Qin X; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Zheng H; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China., Yang J; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China., Liang J; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; Yunnan Provincial Biopharmaceutical Translation and Evaluation Technology Innovation Center, Kunming, China.; Kunming Scientific and Technological Innovation Center for R&D and Industrialization of Vaccines Against Novel and Emerging Highly Pathogenic Pathogens, Kunming, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 26; Vol. 17, pp. 1828345. Date of Electronic Publication: 2026 May 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
